PATENT CLAIM ANALYSIS

Application Number: 15977385
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "017700"]

Abstract:
The application relates to markers for seizures and epilepsy. Polypeptide expression panels or arrays are provided, comprising one or more probes capable of binding specific polypeptides in blood plasma or blood serum of a mammalian subject. Also provided are methods for detecting seizure, methods for predicting seizure, use of sICAM-5 in the treatment of seizure, methods for assessing the effectiveness of a treatment of seizure, and diagnostic kits.

Claim (Index 18):
The method of  claim 13 , wherein said patient has epilepsy when the concentration of IFN-\u03b3 is elevated in said sample relative to control.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 93.0
- Lexical Diversity: 1.61702
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15678784', '15061329', '15234754', '14692338', '13791981']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7667453334909943
- 35 USC 102 Novelty (BERT): 0.6134986307708882
- Combined Prediction Score: 0.7514206632189836
- Mean Citation Score: 390.224786
- Max Citation Score: 654.6244
- Similarity Product: 446.1493270439387

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test